Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents-Reference-Cited by-同舟云学术

Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents

Author:

Kanwal Fasiha¹²,Kramer Jennifer R.¹³^ORCID,Asch Steven M.⁴⁵,Cao Yumei¹³,Li Liang⁶,El‐Serag Hashem B.¹²

Affiliation:

1. Center for Innovations in Quality, Effectiveness and Safety (IQuESt) Michael E. DeBakey Veterans Affairs Medical Center Houston TX

2. Section of Gastroenterology and Hepatology Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center Houston TX

3. Section of Health Services Research, Department of Medicine Baylor College of Medicine Houston TX

4. Center for Innovation to Implementation (Ci2i) Palo Alto Veterans Affairs Medical Center Palo Alto CA

5. Division of Primary Care and Population Health Stanford University Palo Alto CA

6. Department of Biostatistics University of Texas MD Anderson Cancer Center Houston TX

Funder

Investigator-initiated grant from Gilead Sciences to Dr. Hashem El-Serag

Veterans Administration Center for Innovations in Quality, Effectiveness and Safety

Center for Gastrointestinal Development, Infection and Injury

Publisher

Wiley

Subject

Hepatology

Link

Reference28 articles.

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献